Literature DB >> 6791951

Distribution of aldose reductase in ocular tissues.

T S Kern, R L Engerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6791951     DOI： 10.1016/s0014-4835(81)80066-8

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN： 0014-4835            Impact factor:   3.467


× No keyword cloud information.
  13 in total

Review 1.  Understanding the role of aldose reductase in ocular inflammation.

Authors:  U C S Yadav; S K Srivastava; K V Ramana
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

2.  Topical aldose reductase inhibitor.

Authors:  D Coster
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

3.  Long-term effect of Trigonella foenum graecum and its combination with sodium orthovanadate in preventing histopathological and biochemical abnormalities in diabetic rat ocular tissues.

Authors:  Anju Preet; M R Siddiqui; A Taha; J Badhai; M E Hussain; P K Yadava; N Z Baquer
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

4.  Improvement of corneal fluorescein staining in post cataract surgery of diabetic patients by an oral aldose reductase inhibitor, ONO-2235.

Authors:  H Fujishima; K Tsubota
Journal:  Br J Ophthalmol       Date:  2002-08       Impact factor: 4.638

5.  Immunohistochemical distribution of aldose reductase.

Authors:  T S Kern; R L Engerman
Journal:  Histochem J       Date:  1982-05

6.  Diabetes-induced impairment in visual function in mice: contributions of p38 MAPK, rage, leukocytes, and aldose reductase.

Authors:  Chieh Allen Lee; Guangyuan Li; Mansi D Patel; J Mark Petrash; Beth Ann Benetz; Alex Veenstra; Jaume Amengual; Johannes von Lintig; Christopher J Burant; Johnny Tang; Timothy S Kern
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-02       Impact factor: 4.799

7.  Effects of aldose reductase inhibition on the retina and health indices of streptozotocin-diabetic rats.

Authors:  W M Kozak; N A Marker; K K Elmer
Journal:  Doc Ophthalmol       Date:  1986       Impact factor: 2.379

8.  Topical aldose reductase inhibitor for correcting corneal endothelial changes in diabetic patients.

Authors:  N Ohguro; M Matsuda; Y Ohashi; M Fukuda
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

9.  Effects of long-term treatment with ranirestat, a potent aldose reductase inhibitor, on diabetic cataract and neuropathy in spontaneously diabetic torii rats.

Authors:  Ayumi Ota; Akihiro Kakehashi; Fumihiko Toyoda; Nozomi Kinoshita; Machiko Shinmura; Hiroko Takano; Hiroto Obata; Takafumi Matsumoto; Junichi Tsuji; Yoh Dobashi; Wilfred Y Fujimoto; Masanobu Kawakami; Yasunori Kanazawa
Journal:  J Diabetes Res       Date:  2013-03-13       Impact factor: 4.011

Review 10.  The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient.

Authors:  Mara Lorenzi
Journal:  Exp Diabetes Res       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.